The treat-to-target (T2T) concept has improved outcomes for patients with diabetes,
hypertension and rheumatoid arthritis. This therapeutic strategy involves choosing a well …

Objectives Systemic lupus erythematosus (SLE) is a common systemic autoimmune disease
that may lead to considerable physical, psychological, and socioeconomical burden. In …

Objective To achieve consensus on a definition of remission in SLE (DORIS). Background
Remission is the stated goal for both patient and caregiver, but consensus on a definition of …

Treat-to-target strategies have changed the approach to management of many chronic
conditions, with improvements in patient outcomes. The key to success of treat to target is …

Background Remission and low disease activity (LDA) have been proposed as the treatment
goals for patients with systemic lupus erythematosus (SLE). Several definitions for each …

Objectives To investigate the impact of remission and lupus low disease activity state
(LLDAS) on health-related quality of life (HRQoL) in systemic lupus erythematosus. Methods …

Objective: To determine the prevalence of adverse health-related quality of life (HRQoL)
outcomes in patients with SLE who achieved an adequate clinical response after a 52-week …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a relapsing-
remitting course that can affect various organs or systems, leading to a broad spectrum of …

Background Remission or the lowest possible disease activity is the main target in the
management of systemic lupus erythematosus (SLE). Anyway, conflicting data are present in …

A few decades ago, the therapy goal of patients with systemic lupus erythematosus (SLE)
was survival and the prevention of organ failure. Today, clinical remission and low disease …